SCHEMBL24704071

SCHEMBL24704071

CCOC(=O)CC1(C)CCC(=O)C1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ ALOX15 P16050 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ TSHR P16473 1/20 0.36
▸ GAA P10253 2/20 0.36
▸ MGAM O43451 1/20 0.34
▸ SI P14410 1/20 0.34
▸ MGAM2 Q2M2H8 1/20 0.34
▸ ELANE P08246 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CTDSP1 Q9GZU7 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ GSK3A P49840 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26000500 1.00 KMT2A (0.43) KMT2AL3MBTL1ALOX15CYP2D6TSHR
SCHEMBL26000503 1.00 KMT2A (0.43) KMT2AL3MBTL1ALOX15CYP2D6TSHR
SCHEMBL30108992 0.88 ALDH1A1 (0.34) KMT2AL3MBTL1MAPTKDM4EALDH1A1
SCHEMBL30108966 0.85 PRKCA (0.39) KMT2AL3MBTL1TSHRALDH1A1
SCHEMBL30108855 0.84 TP53 (0.42) TSHRGAAMAPTKDM4EALDH1A1
SCHEMBL30108918 0.84 TSHR (0.34) KMT2AL3MBTL1TSHRGAAMAPT
SCHEMBL30114958 0.83 KMT2A (0.39) KMT2AL3MBTL1ALOX15CYP2D6TSHR
SCHEMBL30114903 0.83 KMT2A (0.39) KMT2AL3MBTL1ALOX15CYP2D6TSHR
SCHEMBL24704377 0.83 KMT2A (0.39) KMT2AL3MBTL1ALOX15CYP2D6TSHR
SCHEMBL26000511 0.83 KMT2A (0.39) KMT2AL3MBTL1ALOX15CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4101833-B1 PROCESSES FOR PREPARING A (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE SHINETSU CHEMICAL CO (JP) 2023-12-13 — — EP disclosed
US-11731930-B2 Processes for preparing a (1,2-dimethyl-3-methylenecyclopentyl)acetate compound and (1,2-dimethyl-3-methylenecyclopentyl)acetaldehyde SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-22 — — US disclosed
US-11731930-B2 Processes for preparing a (1,2-dimethyl-3-methylenecyclopentyl)acetate compound and (1,2-dimethyl-3-methylenecyclopentyl)acetaldehyde SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-22 — — US disclosed
US-11731930-B2 Processes for preparing a (1,2-dimethyl-3-methylenecyclopentyl)acetate compound and (1,2-dimethyl-3-methylenecyclopentyl)acetaldehyde SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-22 — — US disclosed
US-20230002305-A1 PROCESSES FOR PREPARING A (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-01-05 — — US disclosed
US-20230002305-A1 PROCESSES FOR PREPARING A (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-01-05 — — US disclosed
EP-4101833-A1 PROCESSES FOR PREPARING A (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE Shin-Etsu Chemical Co., Ltd. (JP) 2022-12-14 — — EP disclosed
EP-4101833-A1 PROCESSES FOR PREPARING A (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE Shin-Etsu Chemical Co., Ltd. (JP) 2022-12-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11731930-B2 Processes for preparing a (1,2-dimethyl-3-methylenecyclopentyl)acetate compound and (1,2-dimethyl-3-methylenecyclopentyl)acetaldehyde ADH1C, AKR1C4, AKR1C2 KMT2A 471/4885L3MBTL1 2283/4885ALOX15 922/4885
US-20230002305-A1 PROCESSES FOR PREPARING A (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETATE COMPOUND AND (1,2-DIMETHYL-3-METHYLENECYCLOPENTYL)ACETALDEHYDE ADH1C, AKR1C4, AKR1C2 KMT2A 471/4885L3MBTL1 2283/4885ALOX15 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback